Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy (Q45892920)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 November 2015
edit
Language Label Description Also known as
English
Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy
scientific article published on 4 November 2015

    Statements

    Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit